5 pending office actions • 2 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Cugene Inc. | 3 |
| Aravive Inc. | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18034499 | NOVEL BIFUNCTIONAL MULTISPECIFIC ANTAGONISTS CAPABLE OF INHIBITING MULTIPLE LIGANDS OF TGF-BETA FAMILY AND USES THEREOF | Unknown | BRISTOL, LYNN ANNE | 1643 | Non-Final OA | Apr 28, 2023 |
| 18016765 | DIAGNOSTIC METHODS FOR CANCER USING AXL DECOY RECEPTORS | Aravive Inc. | DENT, ALANA HARRIS | 1643 | Non-Final OA | Jan 18, 2023 |
| 17784305 | CYTOKINE-BASED BIOACTIVATABLE DRUGS AND METHODS OF USES THEREOF | Cugene Inc. | GURLEY, JAMI MICHELLE | 1647 | Final Rejection | Jun 10, 2022 |
| 17784186 | NOVEL INTERLEUKIN-15 (IL-15) FUSION PROTEINS AND USES THEREOF | Cugene Inc. | CARTER, SANDRA DILLAHUNT | 1674 | Non-Final OA | Jun 10, 2022 |
| 17618207 | NOVEL INTERLEUKIN-2 VARIANTS AND BIFUNCTIONAL FUSION MOLECULES THEREOF | Cugene Inc. | PATTERSON, SARAH COOPER | 1675 | Final Rejection | Dec 10, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial